The Column Group is a venture capital firm in California that focuses on developing biotechnology companies. Founded 2006 in San Francisco, California, United States by Adriana Tajonar and Peter Svennilson, it invests in early stage ventures, late stage ventures, private equity, seed, series B, series A, series C, and series E rounds. Its portfolio companies include Circle Pharma, Nurix, A2 Biotherapeutics, Plexium, and Tenaya Therapeutics. As of March 2020, The Column Group has made 67 investments. Their most recent investment was on March 17, 2020, when Circle Pharma raised $45M. The Column Group has had 13 exits, the most notable of which include PTC Therapeutics, Peloton Therapeutics, and NGM Biopharmaceuticals. The Column Group has raised three funds, their latest being Column Group IV.